Filing Details

Accession Number:
0000899243-19-014838
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-28 16:01:29
Reporting Period:
2019-05-23
Accepted Time:
2019-05-28 16:01:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1731831 Eidos Therapeutics Inc. EIDX Pharmaceutical Preparations (2834) 463733671
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1742587 Uma Sinha C/O Eidos Therapeutics, Inc.
101 Montgomery Street, Suite 2550
San Francisco CA 94104
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-30 1,081 $12.01 354,312 No 5 A Direct
Common Stock Disposition 2019-05-23 4,200 $27.16 350,112 No 4 S Direct
Common Stock Disposition 2019-05-23 800 $27.88 349,312 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan.
  2. Represents the weighted average sale price of the shares sold ranging from $26.52 to $27.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average sale price of the shares sold ranging from $27.55 to $28.43 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.